₹ 0.5 Cr
Volume Transacted
(Nov 8, 2024)
3.6 K
Stocks Traded
(Nov 8, 2024)
Last Updated on: Nov 09, 2024
Name | Designation |
---|
Ashish Shah | Company Sec. & Compli. Officer |
Ashish Bhuta | Chairman & Managing Director |
Dilip Bhuta | Whole Time Director & CFO |
Hina Mehta | Non-Exec. & Independent Dir. |
KRISHNAN SUBHARAMAN | Independent Director |
Name | Designation |
---|---|
Ashish Shah | Company Sec. & Compli. Officer |
Ashish Bhuta | Chairman & Managing Director |
Dilip Bhuta | Whole Time Director & CFO |
Hina Mehta | Non-Exec. & Independent Dir. |
KRISHNAN SUBHARAMAN | Independent Director |
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Jenburkt Pharmaceuticals Ltd
NSE: JENBURKTPHARMA
PRICE
-
Last updated on:
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
08 Nov 2024 | 1252.95 | 1375 | 1375 | 1235 |
07 Nov 2024 | 1305.05 | 1299.95 | 1330 | 1280 |
06 Nov 2024 | 1232 | 1249 | 1275 | 1205 |
05 Nov 2024 | 1087.15 | 1025 | 1137.7 | 1024 |
04 Nov 2024 | 1013 | 987.15 | 1030 | 978 |
01 Nov 2024 | 987.15 | 974.6 | 989.9 | 974.6 |
31 Oct 2024 | 960.4 | 952.6 | 970 | 951.85 |
30 Oct 2024 | 959.2 | 1019.8 | 1019.8 | 944 |
29 Oct 2024 | 983 | 1013 | 1018.95 | 957.95 |
28 Oct 2024 | 1013.55 | 969.8 | 1019.8 | 920.2 |
Date | Price (₹) |
---|---|
08 Nov 2024 | 1252.95 |
07 Nov 2024 | 1305.05 |
06 Nov 2024 | 1232 |
05 Nov 2024 | 1087.15 |
04 Nov 2024 | 1013 |
01 Nov 2024 | 987.15 |
31 Oct 2024 | 960.4 |
30 Oct 2024 | 959.2 |
29 Oct 2024 | 983 |
28 Oct 2024 | 1013.55 |
Market Cap
₹ 552 Cr
EPS
₹ 68.7
P/E Ratio (TTM) *
18.3
P/B Ratio (TTM) *
3.5
Day’s High *
1375.0
Day’s Low
₹ 1235.0
DTE *
0.0
ROE *
19.2
52 Week High
₹ 1375.0
52 Week Low
₹ 625.7
ROCE *
25.3
* All values are consolidated
Last Updated time: 09 Nov 9.00 AM
* All values are consolidated
Last Updated time: 09 Nov 9.00 AM
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Jenburkt Pharmaceuticals to announce Quarterly Result
Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5...
29 Oct 202415:24
Jenburkt Pharmaceuticals to declare Quarterly Result
Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2...
19 Jul 202410:24
Jenburkt Pharmaceuticals to conduct AGM
Jenburkt Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the compa...
24 Jun 202409:36
Board of Jenburkt Pharmaceuticals recommends final dividend
Jenburkt Pharmaceuticals announced that the Board of Directors of the Company at its meeti...
29 May 202410:57
Jenburkt Pharmaceuticals schedules board meeting
Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2...
21 May 202415:36
Jenburkt Pharmaceuticals to announce Quarterly Result
Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6...
20 Jan 202412:45
FAQs for Board of Directors of Jenburkt Pharmaceuticals Ltd
How are members of Jenburkt Pharmaceuticals Ltd Board of Directors selected?
Can shareholders interact with the Jenburkt Pharmaceuticals Ltd Board of Directors?
How often does the Jenburkt Pharmaceuticals Ltd Board of Directors meet?
What are the responsibilities of the Jenburkt Pharmaceuticals Ltd Board of Directors?
Who are the current members of the Board of Directors at Jenburkt Pharmaceuticals Ltd?
Unlimited trading at just
Rs. 199*